BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23855456)

  • 1. Intravenous administration of desmopressin acetate to reverse acetylsalicylic acid-induced coagulopathy in three dogs.
    Di Mauro FM; Holowaychuk MK
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):455-8. PubMed ID: 23855456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
    Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
    J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument.
    Callan MB; Giger U
    Am J Vet Res; 2002 Dec; 63(12):1700-6. PubMed ID: 12492285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the vasopressin analogue desmopressin for polyuria and bleeding disorders.
    Nichols R; Hohenhaus AE
    J Am Vet Med Assoc; 1994 Jul; 205(2):168-73. PubMed ID: 7928567
    [No Abstract]   [Full Text] [Related]  

  • 5. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
    Brassard JA; Meyers KM
    Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
    Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
    Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.
    Sheridan DP; Card RT; Pinilla JC; Harding SM; Thomson DJ; Gauthier L; Drotar D
    Can J Surg; 1994 Feb; 37(1):33-6. PubMed ID: 8306217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of desmopressin (DDAVP) in controlling aspirin-induced coagulopathy after cardiac surgery.
    Kam PC
    Heart Lung; 1994; 23(4):333-6. PubMed ID: 7960860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of intraoperative coagulopathy in a patient with neurofibromatosis type I with intravenous desmopressin (DDAVP).
    Lighthall GK; Morgan C; Cohen SE
    Int J Obstet Anesth; 2004 Jul; 13(3):174-7. PubMed ID: 15321397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimeric analysis of von Willebrand factor before and after desmopressin acetate (DDAVP) administration intravenously and subcutaneously in male beagle dogs.
    Kraus KH; Turrentine MA; Johnson GS
    Am J Vet Res; 1987 Sep; 48(9):1376-9. PubMed ID: 3499101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostatic control in platelet dysfunction and abnormality by DDAVP].
    Mito M; Higuchi W; Fuse I; Hattori A; Shibata A
    Nihon Rinsho; 1992 Feb; 50(2):355-9. PubMed ID: 1613990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of desmopressin on immune-mediated haemorrhagic disorders due to canine monocytic ehrlichiosis: a preliminary study.
    Giudice E; Giannetto C; Gianesella M
    J Vet Pharmacol Ther; 2010 Dec; 33(6):610-4. PubMed ID: 21108506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
    Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
    Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.
    Salzman EW; Weinstein MJ; Weintraub RM; Ware JA; Thurer RL; Robertson L; Donovan A; Gaffney T; Bertele V; Troll J
    N Engl J Med; 1986 May; 314(22):1402-6. PubMed ID: 3517650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin (DDAVP) and hemostasis.
    Lethagen S
    Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN; Meyers KM; Brassard JA; Wardrop KJ
    Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis.
    Lazenby WD; Russo I; Zadeh BJ; Zelano JA; Ko W; Lynch CC; Isom OW; Krieger KH
    Circulation; 1990 Nov; 82(5 Suppl):IV413-9. PubMed ID: 2225433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.